Navigation Links
Life Technologies Announces Second Quarter 2011 Results
Date:7/28/2011

rest expense (FSP APB14-1)

0.03

0.03Business integration and other charges

0.08

0.09Amortization of acquisition related expenses

0.26

0.21Non-GAAP earnings per share$0.89$0.91(2%)Business Highlights:

  • Cell Systems division non-GAAP revenue was $243 million in the second quarter, an increase of 5 percent over the same period last year.  Excluding the impact from currency, organic revenue grew 4 percent year over year.  Mid teens growth in the BioProduction business was tempered by slower growth in other product areas, which were negatively impacted by continued funding pressures in the US and Europe, and the temporary slowdown in China.
  • Molecular Biology Systems division non-GAAP revenue was $432 million, a decline of less than 1 percent over prior year.  Excluding the impact from currency, organic revenue for the division declined 2 percent.  Strong sales of qPCR consumables and molecular testing kits sold into applied markets were offset by slower growth in government funded accounts in the US and Europe as well as the temporary slowdown in China.
  • Genetic Systems division non-GAAP revenue was $265 million in the second quarter, an increase of 12 percent over the same period last year.  Excluding the impact from currency, revenue increased 11 percent.  Strong sales of the Ion Torrent PGM™ and the 5500 Series Genetic Sequencer were partially offset by reduced demand for CE instruments, the result of continued funding pressures in government funded accounts, as well as lower sales of next generation sequencing consumables as the 5500 ramps up.
  • Regional revenue growth rates for the quarter compared to the same quarter of the prior year were as follows: the Americas grew 3 percent, Europe 2 percent, Asia Pacific 3 percent and Japan grew 8 percent.
  • The company called and settled $350 million of 3.25% Convertible Senior Notes due 2025.  <
    '/>"/>

  • SOURCE Life Technologies Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. Synterra Energy Merges Key Technologies to Commercialize Next Generation Integrated Bio-refinery
    2. Life Technologies Introduces First and Only USDA-Approved Real-Time PCR Test to Detect Swine Influenza Virus
    3. Life Technologies Launches New Distribution Center in India
    4. Biobanking: Technologies and Global Markets
    5. Stem Cell Technologies: World Market Outlook 2011-2021
    6. Wound Management Technologies Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT
    7. CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification
    8. Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US
    9. Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies
    10. Life Technologies Launches Highly Efficient Stem Cell Reprogramming Technology
    11. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ... only negative is the housing market remaining soft. , This ...
    (Date:12/24/2014)... The report expects global cell isolation and ... also provides a carefully analyzed data about the vital ... market. , Full Copy of Report @ http://bit.ly/1yUxy0T ... for cell expansion will keep witnessing growth at an ... to be driven by rapid technological advancements, government funding ...
    (Date:12/24/2014)... , Dec. 23, 2014 Vermillion, Inc. ... on gynecologic disease, announced today that investors including ... Birchview Fund LLC and several Vermillion directors have ... shares of Vermillion,s common stock and warrants to ... a private placement.  Under the ...
    (Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
    Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
    ... Primary ... SAN DIEGO, May 27 Favrille, Inc. (Nasdaq:,FVRL) ... trial,of Specifid(TM) following Rituxan(R) in patients with follicular B-cell,non-Hodgkin,s ... Analysis of time to progression (TTP), the primary endpoint ...
    ... May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), ... research,and development outsourcing company with operations in ... that it has appointed Dr. Peng Wang ... http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior to ...
    ... SAN DIEGO, May 23 Amylin Pharmaceuticals,Inc. (Nasdaq: ... Stockholders on,Friday, May 30, 2008 at 11:00 a.m. PT ... the Annual Meeting, Daniel M.,Bradbury, President and Chief Executive ... The live presentation will be Web cast, and ...
    Cached Biology Technology:Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma 2Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma 3WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology 2
    (Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
    (Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
    (Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
    Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
    ... with fossils led to Natural Sciences and Engineering Research Council ... the oldest known reptile that stands on two legs. ... years of research excellence by joining the ranks of the ... will induct him as a fellow during its annual conference, ...
    ... pinpointed a natural ingredient of human blood that effectively ... from infecting immune cells and multiplying. The virus blocker ... to full-blown AIDS and—because it works in a different ... of another class of drugs in the fight against ...
    ... the influenza virus that killed 50 million people in 1918, ... to how the virus killed so quickly and efficiently. , ... a team led by University of Wisconsin-Madison virologist Yoshihiro Kawaoka ... influenza strain - unleashes an immune response that destroys the ...
    Cached Biology News:Old dinosaur research leads to new honor 2Discovery of an HIV inhibitor in human blood points to new drug class 2Discovery of an HIV inhibitor in human blood points to new drug class 3Study uncovers a lethal secret of 1918 influenza virus 2Study uncovers a lethal secret of 1918 influenza virus 3
    ... The Z-Competent E. coli Transformation Buffer ... of competent E. coli cells for simple ... method completely eliminates the requirement for heat ... transformation can be performed by adding DNA ...
    Request Info...
    Buffer used for mitocapture assays....
    ... automated perfusion system. For real-time or ... biophysics, electrochemistry, or general liquid-handling research ... millisecond accuracy Run experiments automatically ... accuracy and flexibility Turnkey perfusion ...
    Biology Products: